Maravai LifeSciences Holdings Inc (MRVI)

43.15 +1.66  +4.00% NASDAQ Nov 29, 10:23 USD

Maravai LifeSciences Holdings Cash from Operations (Quarterly):

165.83M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 165.83M
March 31, 2021 38.72M
Dec. 31, 2020 79.43M
Sept. 30, 2020 51.43M
June 30, 2020 11.62M
March 31, 2020 9.713M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Benchmarks

Arrowhead Pharmaceuticals Inc -24.12M
Cassava Sciences Inc -14.76M
Agios Pharmaceuticals Inc -85.18M

Cash from Operations (Quarterly) Range, Past 5 Years

Minimum 9.713M Mar 2020
Maximum 165.83M Jun 2021
Average 59.46M





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.